Core Insights - Vivos Therapeutics is expanding its alliance model into two additional locations in Colorado, driven by patient preference for Vivos CARE treatment over CPAP by nearly 2 to 1 [1][3] - The company is actively seeking further alliances or acquisitions of sleep medicine practices to support its national expansion goals [1][10] Group 1: Expansion and Strategic Alliances - Vivos has announced the expansion of its strategic marketing and distribution alliance with Rebis Health into two new facilities in the greater Denver area, with plans for further nationwide expansion [2] - The company is exploring alliances or acquisitions of over 2,500 accredited sleep medicine and testing groups across major U.S. cities to enhance revenue growth and reduce cash burn [10] Group 2: Patient Preference and Treatment Efficacy - Initial data from the alliance indicates a Vivos treatment case acceptance rate of 64%, significantly higher than the acceptance of CPAP [3] - Vivos CARE treatment offers advantages over CPAP, including the potential for rehabilitation of airway functionality and symptom reduction, with many patients not requiring further intervention after treatment [5] Group 3: Financial Performance and Revenue Potential - The average revenue per case for Vivos is over $4,700, with gross margins around 70%, indicating a potential for significantly higher profitability compared to previous distribution models [7] - The company anticipates that revenue growth will accelerate starting in 2025 as patient acceptance of Vivos treatment options continues to rise [9]
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide